alexa Ventricular Hypertrophy Scholarly Peer-review Journal|omicsgroup|journal Of Vascular Medicaine And Surgery

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Ventricular Hypertrophy Scholarly Peer-review Journal

It is clinical condition which is characterized by thickening of ventricular walls in the heart. Mostly left ventricular hypertrophy is common. Common cause of ventricular hypertrophy is hypertension, aortic valve stenosis, Hypertrophic cardiomyopathy and Athletic training. It can be manged by using ACE inhibitors, Angiotensin II receptor blockers, Thiazide diuretics, Beta blockers and Calcium channel blockers.Scholarly peer review is the process of subjecting an author'sscholarlywork, research, or ideas to the scrutiny of others who are experts in the same field, before a paper describing this work is published in a journal. The work may be accepted, considered acceptable with revisions, or rejected. Peer review requires a community of experts in a given (narrowly defined) field, who are qualified and able to perform reasonably impartial review.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on November, 2020